# Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer

> **NCT01929499** · PHASE2 · UNKNOWN · sponsor: **Yanjuan Zhu** · enrollment: 210 (estimated)

## Conditions studied

- Colonic Neoplasms

## Interventions

- **BIOLOGICAL:** cytokine-induced killer cells

## Key facts

- **NCT ID:** NCT01929499
- **Lead sponsor:** Yanjuan Zhu
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09
- **Primary completion:** 2016-08
- **Final completion:** 2019-08
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2013-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01929499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01929499, "Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01929499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
